** Shares of Algorae Pharmaceuticals 1AI.AX rise as much 14.35 to A$0.008, their highest levels since Nov 21
** The pharma co says it received positive outcomes from pre-clinical studies for drug candidate AI-168
** Says drug demonstrates "statistically significant" cardio-protective qualities
** Stock on track for second straight session of gains
** Over 9.6 mln shares change hands, compared with the 30-day average volume of 1.4 mln
** 1AI stock down 20% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。